StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA) on Watch as Pfizer/BioNTech SE Three Dose Regimen Neutralizes Omicron
December 8, 2021 7:04 AM
Moderna (NASDAQ: MRNA) shares are on watch as rivals Pfizer/BioNTech ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Trader Talk
Next Articles
Moderna (MRNA) Reports Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update
December 10, 2021 7:00 AM
Moderna (MRNA) Will Host Conference Call on Phase 1 Interim Analysis for mRNA Flu Vaccine on Friday, December 10
December 9, 2021 4:44 PM